This study investigates the effectiveness and safety of an investigational medication for people with moderate-to-severe atopic dermatitis (AD). Atopic dermatitis is a skin condition that causes red, itchy, and inflamed skin. The study is for participants who have not responded well to other treatments, such as biologic medications or oral …
Who can participate: Adults aged 18 to 65 years with a diagnosis of chronic pain for at least six months, who have not responded to standard treatments, are eligible to participate.Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The study will involve …
This study investigates the use of an investigational medication in people with chronic immune thrombocytopenia (ITP). ITP is a condition where the immune system mistakenly attacks and destroys platelets, which are cells that help blood clot. This can lead to easy or excessive bruising and bleeding. Participants in this study …
This study investigates the safety and effects of an investigational medication in people with certain blood cancers, known as hematological malignancies. These include diseases like acute myeloid leukemia (AML) and other related conditions. The purpose is to understand how the medication works in the body and its potential anti-cancer effects.Participants …
This study investigates the effects of an investigational medication on pain symptoms in people with Fabry disease. Fabry disease is a genetic disorder that affects the body's ability to break down a specific type of fat, leading to symptoms like pain in the hands, feet, and abdomen. The purpose of …
This study investigates the safety and effects of an investigational medication in people with HER2+ tumors. HER2+ tumors are a type of cancer that has a high level of a protein called human epidermal growth factor receptor 2, which can affect how cancer cells grow. The study will test the …
This study investigates the long-term safety of an investigational medication in patients with multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. The purpose of this study is to provide continued access to the investigational medication for patients who have completed a previous study with …
This study investigates an investigational medication for people with relapsed/refractory multiple myeloma (RRMM) and relapsed/refractory light chain amyloidosis (RRLCA). Multiple myeloma is a type of cancer that affects plasma cells in the bone marrow, while light chain amyloidosis involves abnormal proteins that can damage organs. The study aims to find …
This study investigates the safety and effectiveness of an investigational medication in children with achondroplasia, a genetic condition that affects bone growth. Achondroplasia is caused by a mutation in the FGFR3 gene, leading to shorter stature and other skeletal abnormalities. The purpose of this study is to evaluate how well …
This study investigates chronic graft versus host disease (cGVHD), a condition that can occur after a stem cell or bone marrow transplant. In cGVHD, the transplanted donor cells attack the recipient's body, causing inflammation and scarring in various organs. The purpose of this study is to determine if adding an …
